STAVROPOULOS NICKOLAS 4

4 · Ameresco, Inc. · Filed Feb 13, 2026

AI-generated summary of this filing

Updated Feb 13, 2026

Ameresco (AMRC) Director Nickolas Stavropoulos Exercises Options, Sells Shares

What Happened

Director Nickolas Stavropoulos exercised stock options to acquire 445 shares (200 on 2026-02-12 and 245 on 2026-02-13) at $16.33 per share (total cost ≈ $7,267). He then sold those same 445 shares in open-market transactions (200 on 2/12 at a weighted avg $34.00; 245 on 2/13 at a weighted avg $34.05), generating total proceeds of about $15,142. The transactions were effected under a Rule 10b5-1 trading plan.

Key Details

Transaction dates: 2026-02-12 and 2026-02-13; Form filed 2026-02-13 (appears timely).
Option exercise details: 200 shares @ $16.33 (2/12) and 245 shares @ $16.33 (2/13); total exercise cost ≈ $7,267.
Sales: 200 shares @ weighted avg $34.00 (2/12) = $6,800; 245 shares @ weighted avg $34.05 (2/13) = $8,342; total proceeds ≈ $15,142.
Footnotes: Sales were made pursuant to a Rule 10b5-1 plan adopted Sept 8, 2025 (F1). The reported weighted-average sale price reflects multiple trades in a range of $34.02–$34.15 (F2). The options exercised had a vesting schedule beginning April 24, 2020, with remaining vesting in four annual installments (F3).
Derivative reporting: The filing also shows the related derivative interests (options) being disposed at $0.00 — this reflects the surrender/termination of the option instruments upon exercise.
Shares owned after the transactions: not specified in the provided data.

Context

These were option exercises followed by immediate open-market sales (a cashless/stock-sell-off pattern), which is commonly used to cover exercise costs and tax obligations. Because the sales were made under a pre-established 10b5-1 plan, they are typically considered routine trading arrangements rather than ad-hoc insider selling.

Form 4

Period: 2026-02-12

Director

Transactions

Exercise/Conversion
Class A Common Stock
2026-02-12$16.33/sh+200$3,266→ 14,311 total
Sale
Class A Common Stock
[F1]
2026-02-12$34.00/sh−200$6,800→ 14,111 total
Exercise/Conversion
Class A Common Stock
2026-02-13$16.33/sh+245$4,001→ 14,356 total
Sale
Class A Common Stock
[F1][F2]
2026-02-13$34.05/sh−245$8,342→ 14,111 total
Exercise/Conversion
Stock Option (right to purchase)
[F3]
2026-02-12−200→ 23,700 total
Exercise: $16.33Exp: 2029-04-23→ Class A Common Stock (200 underlying)
Exercise/Conversion
Stock Option (right to purchase)
[F3]
2026-02-13−245→ 23,455 total
Exercise: $16.33Exp: 2029-04-23→ Class A Common Stock (245 underlying)

Footnotes (3)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.02 to $34.15, inclusive. The reporting person undertakes to provide to Ameresco, Inc., any security holder of Ameresco, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
[F3]Of the shares subject to the option, 20% vested on April 24, 2020, and the remainder vested in four equal installments on each of the subsequent four anniversaries of such date.

Signature

/s/ David J. Corrsin, attorney-in-fact|2026-02-13

1 file